Benign prostatic hyperplasia: the best treatment.
- 22 July 1989
- Vol. 299 (6693) , 215-216
- https://doi.org/10.1136/bmj.299.6693.215
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Use of stents for treating obstruction of urinary outflow in patients unfit for surgery.BMJ, 1989
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- The Testes and the ProstateNew England Journal of Medicine, 1987
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- The Natural History of Untreated “Prostatism”British Journal of Urology, 1981
- The Significance of the Symptoms Associated with Bladder Outflow ObstructionUrologia Internationalis, 1978
- The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH 582) on benign prostatic hypertrophyBritish Journal of Surgery, 1971
- A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophyBritish Journal of Surgery, 1971
- THE QUESTION OF CASTRATION FOR ENLARGED PROSTATEAnnals of Surgery, 1896